# Enobia Pharma Corp: Form D filings

Enobia Pharma Corp, a biotechnology company in Montreal, Quebec, Canada, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on August 24, 2011, reports $20 million sold of a $40 million offering to 3 investors.

Find out what Enobia Pharma Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Enobia%20Pharma%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Enobia%20Pharma%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fenobia-pharma-corp-1412621)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Enobia%20Pharma%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Enobia%20Pharma%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fenobia-pharma-corp-1412621)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2901 RACHEL ST., SUITE 23, Montreal, Quebec, Canada, H1W 4
- Phone: (514) 596-2901
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2007
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1412621

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 24, 2011 | New notice | $40,000,000 | $20,000,000 | $20,000,000 | 3 | Aug 9, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1412621/000114420411049367/0001144204-11-049367-index.htm) |
| Apr 1, 2011 | New notice | $46,969,070 | $15,000,000 | $31,969,070 | 7 | Mar 21, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1412621/000114420411019511/0001144204-11-019511-index.htm) |
| Dec 13, 2010 | Amendment | $50,000,000 | $50,000,000 | $0 | 8 | Aug 5, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1412621/000114420410065972/0001144204-10-065972-index.htm) |
| Aug 28, 2009 | New notice | $50,000,000 | $15,000,000 | $35,000,000 | 8 | Aug 5, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1412621/000141262109000002/0001412621-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Thomas L. Schuetz | Director |  |
| Luc L. Mainville | Director |  |
| Richard L. Meadows | Director |  |
| Frederic L. Price | Director |  |
| Jonathan L. Silverstein | Director |  |
| Jeffrey Mack | Executive Officer |  |
| David L. Bonita | Director |  |
| Robert Heft | Executive Officer, Director |  |
| Eric L. Trachtenberg | Executive Officer |  |

[Every Form D from the week of Aug 22, 2011](https://specstream.ai/data/form-d/week/2011-08-22) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Enobia Pharma Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).